X-ZELL officially incorporated in Singapore

X-ZELL officially incorporated in Singapore Singapore, October 2018 – X-ZELL Inc., only recently named one of Asia’s 20 most innovative health tech start-ups, is coming to Singapore. According to X-ZELL CEO, Dr Sebastian Bhakdi, the rare cell detection specialist’s...

X-ZELL among 16 most innovative health-tech start-ups in Asia

X-ZELL among 16 most innovative health-tech start-ups in Asia Singapore, September 2018 – Galen Growth, a Singapore-based analytics and advisory firm specialising in cutting-edge healthcare technology, has named X-ZELL Inc. as one of the 16 most innovative health...

X-ZELL Blog Episode 5

X-ZELL Blog MRI's role in prostate cancer screening The role of magnetic resonance imaging (MRI) as a tool to detect and stage clinically significant prostate cancer (csPCa) continues to cause controversy among the medical community. The 19th Asia-Pacific Prostate...

X-ZELL technology featured in British urology journal

Ground-breaking X-ZELL research featured in BJU International Oxford, August 2018 – X-ZELL Inc. CEO, Dr Sebastian Bhakdi, has published new research into the utility of tumour-derived Circulating Endothelial Cells (tCEC) for the detection of early-stage prostate...